Back
Cellectar Biosciences Stock Price Chart

Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
CLRB
Cellectar Biosciences
Last Price:
$0.30
Seasonality Move:
-11.4%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cellectar Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Buy |
20-day SMA: | 0.31 | Sell |
50-day SMA: | 0.31 | Sell |
200-day SMA: | 1.32 | Sell |
8-day EMA: | 0.28 | Buy |
20-day EMA: | 0.26 | Buy |
50-day EMA: | 0.17 | Buy |
200-day EMA: | 0.06 | Buy |
Cellectar Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 49.27 | Sell |
Chaikin Money Flow: | 226267 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.37) | Sell |
Bollinger Bands (100): | (0.04 - 0.9) | Sell |
Cellectar Biosciences Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.30 while CLRB 8-day simple moving average is 0.28, which is a Buy signal.
-
The stock price of CLRB is 0.30 while Cellectar Biosciences 20-day SMA is 0.31, which makes it a Sell.
-
Cellectar Biosciences 50-day simple moving average is 0.31 while CLRB share price is 0.30, making it a Sell technically.
-
CLRB stock price is 0.30 and Cellectar Biosciences 200-day simple moving average is 1.32, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
22
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a SellThe current Cellectar Biosciences [CLRB] share price is $0.30. The Score for CLRB is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
13.8M
Price in USD:
0.30
Share Volume:
226.3K
Cellectar Biosciences 52-Week Range
52-Week High:
3.51
52-Week Low:
0.22
Sell
22
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?The Cellectar Biosciences stock price is 0.30 USD today.
-
Will CLRB stock go up or go down?Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Cellectar Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
-
Cellectar Biosciences share price is 0.30 while CLRB 8-day exponential moving average is 0.28, which is a Buy signal.
-
The stock price of CLRB is 0.30 while Cellectar Biosciences 20-day EMA is 0.26, which makes it a Buy.
-
Cellectar Biosciences 50-day exponential moving average is 0.17 while CLRB share price is 0.30, making it a Buy technically.
-
CLRB stock price is 0.30 and Cellectar Biosciences 200-day simple moving average is 0.06, creating a Buy signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.93 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
-
CLRB Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Cellectar Biosciences is a Buy
-
Cellectar Biosciences Relative Strength Index (RSI) is 49.27, which suggest Cellectar Biosciences is oversold
-
The Bollinger Bands (25) for Cellectar Biosciences is (0.27 - 0.37), which suggest Cellectar Biosciences is a Sell
-
The Bollinger Bands (100) for Cellectar Biosciences is (0.04 - 0.9), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.